Advertisement |
|
Visualize and Quantify Cellular Interactions in the Tumor Microenvironment What would it mean to your research if you could accurately quantify cellular interactions in the tumor microenvironment? Download the eBook to learn how scientists are using the Phenoptics™ research solution to visualize, analyze, quantify and phenotype immune cells in situ, in FFPE tissue sections and TMAs. Download eBook | | | |
|
|
TABLE OF CONTENTS
|
June 2018 Volume 18, Issue 6 |
| | |
| Research Highlights Reviews Perspectives | | Advertisement | | | | Do you have a career question? The Naturejobs podcast features one-on-one Q&As, panel discussions and other exclusive content to help scientists with their careers. Hosted on the Naturejobs blog, the podcast is also available on iTunes and Soundcloud. Listen today! | | | | |
Advertisement |
|
New Whitepapers: How 3D Models Facilitate Studying Hypoxia in Cancer Model systems are critical to elucidating molecular pathways underscoring cellular responses to hypoxia. Compared to monolayer cultures, 3D models better replicate the in vivo tumor conditions but which model is best suited for your experiment? Learn more about Cellular Adaptations and Experimental Models | | | |
|
|
Advertisement |
|
|
|
|
Research Highlights | |
|
| | Take a left here p337 Anna Dart doi:10.1038/s41568-018-0011-x Whether lymph node metastases can be a source of cancer cells for distant metastases has been debated. Now, two studies have used mouse models to show that tumour cells can colonize distant organs by invading lymph node blood vessels. | | | | Pap seeking new challenges pp338 - 339 Ulrike Harjes doi:10.1038/s41568-018-0013-8 Wang et al. have developed a diagnostic tool (based on the widely used Papanicolaou (Pap) test) to detect endometrial and ovarian cancer in patients by using PCR-based analyses of genetic mutations and aneuploidy. | | | | Stop the shedding pp338 - 339 Sarah Seton-Rogers doi:10.1038/s41568-018-0012-9 Ferrari de Andrade et al. find that monoclonal antibodies that prevent shedding of MICA and MICB from tumour cells can restore antitumour immunity by natural killer cells. | | | | Cell genesis p339 Anna Dart doi:10.1038/s41568-018-0014-7 Han et al. have identified a new tumour-induced immune cell population in the spleen that can promote tumour growth through production of the neurotrophic factor artemin. | | | | | |
Reviews | |
|
|
|
Known and novel roles of the MET oncogene in cancer: a coherent approach to targeted therapy pp341 - 358 Paolo M. Comoglio, Livio Trusolino & Carla Boccaccio doi:10.1038/s41568-018-0002-y The MET oncogene encodes a receptor tyrosine kinase with pleiotropic functions. In this Review, Comoglio et al. describe the known and novel MET-mediated biological responses in cancer and discuss how clinical trials testing anti-MET therapies should be designed with careful consideration of these oncogenic functions of MET. |
|
Advertisement |
|
nature.com webcasts Nature Research Custom presents a webcast on: Multicolour Digital PCR for ctDNA detection in breast cancer Date: 12 June 2018 Dr. Isaac Garcia-Murillas from ICR will address the technical challenges for clinical utility of liquid biopsy and ctDNA as a biomarker in breast cancer. This webcast has been produced on behalf of the sponsor who retains sole responsibility for content Register for FREE Sponsored by: Stilla Technologies | | |
|
|
Perspectives | |
|
|
|
A history of exploring cancer in context pp359 - 376 Shelly Maman & Isaac P. Witz doi:10.1038/s41568-018-0006-7 In this Timeline article, Maman and Witz describe how much progress has been made in understanding how the tumour microenvironment influences tumour progression since its initial description, highlighting the controversies in the field and the potential of targeting components of the microenvironment for cancer therapy. |
|
|
|
Structural underpinnings of oestrogen receptor mutations in endocrine therapy resistance pp377 - 388 John A. Katzenellenbogen, Christopher G. Mayne, Benita S. Katzenellenbogen, Geoffrey L. Greene & Sarat Chandarlapaty doi:10.1038/s41568-018-0001-z This Opinion article highlights how activating mutations in the gene encoding oestrogen receptor-α (ERα), a major driver in breast cancer, undermine structural features of wild-type ERα that maintain the ‘off-state’ in the absence of oestrogens, thus making ERα constitutively active and endocrine-therapy resistant. |
|
|
|
Too many targets, not enough patients: rethinking neuroblastoma clinical trials pp389 - 400 Jamie I. Fletcher, David S. Ziegler, Toby N. Trahair, Glenn M. Marshall, Michelle Haber et al. doi:10.1038/s41568-018-0003-x This Perspective provides an update on targeted therapy development for neuroblastoma and proposes that clinical trial design needs to be rethought in order to provide rigorous, evidence-based assessment of these new therapies in this rare and often deadly paediatric tumour. |
|
|
|
Advertisement |
|
Nature Briefing is an essential round-up of science news, opinion and analysis, free in your inbox every weekday. With Nature Briefing, we'll keep you updated on the latest research, so you can focus on yours. Click here to sign up. | | | |
|
|
| | | | | | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com | | | | | | |
|
No comments:
Post a Comment